Gaingels

Gaingels is a venture investment syndicate founded in 2014 and based in Burlington, Vermont, dedicated to supporting the LGBT+ community and its allies. The organization invests in companies led by LGBT+ founders and executives at all stages of development, as well as in established firms committed to enhancing their diversity and inclusivity. With a global portfolio comprising over 130 companies and $70 million in investment capital deployed, Gaingels plays a vital role in fostering an inclusive business environment. Additionally, the Gaingels network actively assists its portfolio companies in identifying and recruiting diverse talent for their leadership teams, while cultivating a vibrant community of industry leaders, investors, and entrepreneurs committed to driving positive social change through business initiatives.

Marc Baum

Investor

Jesse Curran

Principal

Rachael Foo

Investor

Paul Grossinger

Co-Founder and General Partner

Todd Havill

Research Operations and Principal, Investment

Surya Jayaweera

Angel Investor

Jennifer Jeronimo

CEO and General Partner

Jake Prigoff

General Partner

Peter Steinberg

General Partner

Alexandra Tanner

Investor

Lorenzo Thione

Managing Director

Past deals in Healthcare

Cofertility

Series A in 2025
Cofertility is a fertility-focused organization that offers a comprehensive ecosystem to support individuals and families throughout their fertility journeys. The company specializes in egg donation and egg-freezing services, facilitating connections between egg donors and recipients. Cofertility allows women to freeze their eggs at no cost when they donate half of their eggs to another family, making fertility services more accessible. By prioritizing a human-centered approach, Cofertility aims to simplify the processes involved in third-party reproduction and fertility care, ensuring users receive the necessary support to pursue their family-building goals.

Ignota Labs

Seed Round in 2025
Ignota Labs is a medical technology company focused on enhancing the drug discovery process by utilizing advanced artificial intelligence methods, including deep learning and machine learning. The company's platform aims to optimize the identification of toxic compounds, which can lead to costly delays and safety errors in bringing new medications to market. By predicting toxic endpoints early in the development process, Ignota Labs not only improves drug safety but also promotes sustainability within the pharmaceutical industry by minimizing environmental harm and waste associated with harmful compounds.

Afynia Laboratories

Seed Round in 2025
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.

Qnovia

Series B in 2024
Qnovia is a biotechnology company that specializes in developing innovative drug delivery systems, focusing particularly on inhalation-based technologies. The company aims to enhance the delivery of a wide range of pharmaceuticals, including nicotine, by creating advanced aerosol devices and formulations that address the limitations of traditional drug delivery methods. Qnovia's platform not only seeks to improve patient outcomes through more effective inhaled therapies but also emphasizes responsible sourcing and transparency in product information. By prioritizing innovation and patient-centric solutions, Qnovia strives to contribute positively to public health and the overall experience of medication delivery.

Arda Therapeutics

Series A in 2024
Arda Therapeutics is a biotechnology company founded in 2021 in the San Francisco Bay Area that focuses on addressing chronic diseases and aging by targeting and eliminating pathogenic cells responsible for these conditions. The company utilizes single-cell data to identify specific pathogenic cells and their markers, allowing for the development of precise therapies that exclusively eliminate these harmful cells. This targeted approach aims to eradicate the entire pathological network while preserving healthy cells, thereby enabling effective treatment without adverse effects on the patient's overall cellular health.

Superluminal Medicines

Series A in 2024
Superluminal Medicines is a biotechnology company specializing in generative biology and chemistry. It employs a unique platform that combines deep biological and chemical expertise, machine learning, and proprietary big data infrastructure to rapidly generate candidate-ready compounds for drug discovery and development. By integrating high-throughput experimental data with advanced algorithms, the company aims to accelerate the identification and optimization of novel drug candidates, improving efficiency and success rates in small molecule drug development compared to traditional methods.

Afynia Laboratories

Seed Round in 2024
Aima Laboratories is a women's health healthcare company that provides innovative solutions to diagnostic and therapeutic difficulties. AIMA is working on the first non-invasive endometriosis diagnostic tool for the market. If you have chronic pelvic/period pain or are having difficulty becoming pregnant, you may have endometriosis.

Grayce

Series A in 2024
Grayce, Inc. is a health care agency based in San Francisco that specializes in providing personalized support for families and employees managing the care of aging adults and children. Established in 2019, Grayce offers a comprehensive range of services, including assistance with insurance, finances, legal plans, medical care, home care, housing, and daily needs. The company emphasizes individualized guidance, ensuring that each member receives dedicated support from a social worker who helps manage their overall care. This includes planning, resource identification, care coordination, and advocacy, empowering family caregivers to effectively navigate the complexities of caring for their loved ones.

OverT Bio

Seed Round in 2024
OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the barriers posed by tumors. By enhancing the effectiveness and durability of immunotherapies, OverT Bio aims to advance the healthcare field's ability to identify and ultimately cure cancer.

Testmate Health

Seed Round in 2024
Testmate Health is a medtech startup and an award-winning spin-off of the University of Geneva, focused on developing innovative healthcare solutions. The company has created a smartphone-compatible test kit that can diagnose diseases with identifiable DNA or RNA sequences, providing results directly at home in just minutes. Its first product is a rapid urine self-test for the four most common sexually transmitted diseases, addressing the urgent need for timely diagnosis, as one million new STDs are diagnosed daily. Traditional testing often requires lab work and can take up to seven days for results. Testmate Health's all-in-one kit is designed for ease of use, allowing users to obtain immediate results that can be scanned by a smartphone for quick access to treatment if necessary. The company is also working on additional test kits for other diseases, aiming to empower individuals to manage their health conveniently from home.

Limbic

Series A in 2024
Limbic is a London-based company that specializes in mental healthcare technology. Founded in 2017, it develops a software development kit (SDK) that leverages machine learning to analyze heart rate data collected from wearable devices like the Apple Watch, allowing for the assessment of users' emotional states. Limbic also offers psychological therapies for adults, focusing on improving mental health through innovative solutions. Its platform supports healthcare professionals by providing tools for stress detection and facilitating clinical assessments, thereby enhancing the efficacy of psychological therapy. By combining AI technology with wearable devices, Limbic aims to address the growing challenges in mental health care and improve patient outcomes.

Ezra AI

Series B in 2024
Ezra AI, Inc. specializes in developing artificial intelligence technology-based investigational devices aimed at early cancer detection. The company utilizes full-body MRI scans enhanced by AI to innovate cancer screening methods. Its initial product, an AI software designed to assist radiologists in interpreting prostate MRI images, has received FDA clearance as a medical device. Founded in 2017, Ezra AI is headquartered in New York, New York, and primarily serves customers in New York and California.

Hone Health

Venture Round in 2024
Hone Health is a men's health platform that provides personalized care through data-driven insights and licensed physician consultations. The company offers a range of services including medications for testosterone optimization, as well as treatments with clomid and anastrozole. Hone Health utilizes telemedicine and FDA-approved testing systems to monitor hormonal changes, allowing users to track their health affordably under professional medical guidance.

Shimmer

Seed Round in 2024
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

BetterBrand

Venture Round in 2024
BetterBrand is a food tech company focused on revolutionizing the refined carbohydrate category by offering healthier alternatives. Its flagship product, The Better Bagel, significantly reduces the carbohydrate content, making it the net carb equivalent of two slices of banana, while also delivering over 25 grams of plant-based protein and containing no added sugars. The company's mission is to empower consumers to enjoy their favorite foods without guilt, thereby addressing the broader health crisis linked to obesity and diabetes, which incurs substantial economic costs globally. BetterBrand's approach combines innovation with a commitment to clean, non-GMO verified ingredients, aiming to promote overall well-being and enhance productivity in society. Founded with the belief that limits should be challenged and that a better world is achievable, BetterBrand seeks to create enjoyable, nutritious food options for all.

Seismic Therapeutic

Series B in 2023
Seismic Therapeutic is a biotechnology company focused on accelerating immunology drug development through the integration of machine learning in the biologics discovery process. Its IMPACT™ platform addresses key challenges in biologics discovery by combining structural biology, protein engineering, and translational immunology. This innovative approach aims to create optimized therapies more efficiently, ultimately benefiting patients with autoimmune diseases and disorders linked to adaptive immune system dysregulation. With a robust pipeline of biologics, Seismic Therapeutic is committed to enhancing the speed and efficacy of drug development in the field of immunology.

Pair Team

Series A in 2023
Pair Team focuses on enhancing primary care infrastructure for vulnerable communities, particularly those served by safety-net systems, Medicaid, and Medicare patients. As a tech-enabled care team, it extends the capabilities of clinical staff by offering personalized, high-touch care experiences. The organization addresses various barriers to healthcare, including transportation issues, housing and food insecurity, and limited mobile access. Pair Team employs a dedicated care team consisting of community health workers, registered nurses, and behavioral health clinicians to deliver comprehensive support tailored to the needs of low-income individuals. Additionally, the company is developing a care delivery platform designed to implement clinical best practices, integrate services with community-based organizations, and streamline administrative tasks, allowing clinicians to dedicate more time to patient care.

Allara Health

Series A in 2023
Allara is a healthcare program focused on providing specialized virtual care for women dealing with complex chronic health conditions, particularly polycystic ovary syndrome. The platform connects patients with medical providers and registered dietitians, offering a comprehensive approach that includes diagnostic testing, prescriptions, and personalized video consultations. Allara emphasizes holistic care, integrating dietary and lifestyle changes alongside nutrition counseling to help women manage their health effectively. Through its virtual appointments, the program aims to simplify access to expert care, enabling patients to track and improve their overall medical wellbeing.

Atropos Health

Venture Round in 2023
Atropos Health is a technology company based in Palo Alto, California, founded in 2019. It specializes in developing a digital prognostogram platform, known as the Atropos Evidence Platform, which transforms health data into actionable real-world evidence. By integrating electronic medical record (EMR) data, the platform generates digital evidence tailored to individual patient outcomes. This enables healthcare institutions, life science companies, and researchers to utilize previously siloed EMR data effectively. The platform aims to close evidence gaps in healthcare, enhance clinical outcomes through data-driven care, and accelerate research initiatives. Atropos Health serves caregivers, healthcare organizations, and risk-bearing entities, contributing to advancements in evidence-based healthcare.

Carenostics

Seed Round in 2023
Carenostics is a health technology company focused on addressing the underdiagnosis, undertreatment, and health inequities associated with chronic diseases. The company employs artificial intelligence and machine learning to analyze patient data collected during routine care. Its detection models integrate seamlessly into providers' electronic health records (EHRs), allowing for the identification of chronic conditions that may have gone undiagnosed. By projecting the potential decline of patients with these conditions, Carenostics enables healthcare providers to prioritize care for individuals who need it most, ultimately aiming to improve health outcomes and reduce disparities in chronic disease management.

Superluminal Medicines

Seed Round in 2023
Superluminal Medicines is a biotechnology company specializing in generative biology and chemistry. It employs a unique platform that combines deep biological and chemical expertise, machine learning, and proprietary big data infrastructure to rapidly generate candidate-ready compounds for drug discovery and development. By integrating high-throughput experimental data with advanced algorithms, the company aims to accelerate the identification and optimization of novel drug candidates, improving efficiency and success rates in small molecule drug development compared to traditional methods.

Remedial Health

Series A in 2023
Remedial Health operates as a wholesale distributor of medicine, catering to the vast network of approximately one million pharmacies and hospitals across Africa. The company addresses the prevalent inefficiencies in the healthcare supply chain, where providers often depend on open-air markets to acquire pharmaceuticals, leading to risks of counterfeit products. By offering a pharmacy operations and procurement management platform, Remedial Health enhances business-to-business access to medications. This platform incorporates technology that simplifies the ordering process and facilitates direct access to retail medicines from manufacturers or distributors, thereby improving workflow management and ensuring a more reliable supply of genuine medications for healthcare providers.

ReflexAI

Seed Round in 2023
ReflexAI develops artificial intelligence tools aimed at enhancing the training and performance of frontline teams across various sectors, including crisis services, emergency response, social services, and healthcare. The company's offerings focus on scalable AI solutions that provide advanced roleplay simulations and intelligent quality assurance, which improve outcomes for human interactions. By automating scoring and reporting processes, ReflexAI's tools help to optimize training efficiency while ensuring consistency and visibility, particularly in veteran mental health services. This approach not only saves time and resources but also empowers agents to deliver better support in critical situations.

Alnair Therapeutics

Pre Seed Round in 2023
Alnair Therapeutics is a preclinical stage precision oncology platform dedicated to developing innovative treatments for difficult-to-treat malignancies. The company has pioneered a unique drug delivery technology that utilizes the distinct characteristics of cancer metabolism to enhance the targeting and penetration of therapeutic agents directly into cancer cells. This approach aims to improve treatment outcomes for patients, positioning Alnair Therapeutics as a potential leader in the field of cancer treatment.

Heading Health

Series A in 2023
Heading Health is a technology-enabled mental health platform dedicated to enhancing access to affordable care. The company provides personalized treatment solutions that utilize evidence-based therapeutics and advanced technologies such as transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. By leveraging these tools, Heading Health aims to deliver effective and convenient mental health services, helping patients achieve meaningful outcomes and improved well-being.

BetterBrand

Series A in 2023
BetterBrand is a food tech company focused on revolutionizing the refined carbohydrate category by offering healthier alternatives. Its flagship product, The Better Bagel, significantly reduces the carbohydrate content, making it the net carb equivalent of two slices of banana, while also delivering over 25 grams of plant-based protein and containing no added sugars. The company's mission is to empower consumers to enjoy their favorite foods without guilt, thereby addressing the broader health crisis linked to obesity and diabetes, which incurs substantial economic costs globally. BetterBrand's approach combines innovation with a commitment to clean, non-GMO verified ingredients, aiming to promote overall well-being and enhance productivity in society. Founded with the belief that limits should be challenged and that a better world is achievable, BetterBrand seeks to create enjoyable, nutritious food options for all.

Glitzi

Venture Round in 2023
Glitzi is a wellness and health platform that connects consumers with certified beauty and wellness professionals across Latin America. It offers a range of services including makeup, hairstyling, massages, spa treatments, and nail care, all delivered directly to clients' doorsteps. This platform aims to facilitate convenient access to beauty and wellness services in the comfort of one's home, catering primarily to women seeking professional care without the need to travel. Through its services, Glitzi enhances the experience of personal care by providing a seamless connection between clients and qualified professionals.

Every Health

Pre Seed Round in 2023
Tech-enabled healthcare solution for the underserved LGBTQIA+ community.

Aether Bio

Venture Round in 2023
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Galileo

Venture Round in 2023
Galileo, Inc. is a technology company that specializes in providing healthcare solutions through a mobile application, enabling direct access to clinical care and expertise via smartphones. Founded in 2014 and headquartered in New York, the company facilitates communication between healthcare providers and patients using advanced telecommunications technologies. Galileo delivers high-touch, data-driven, multi-specialty care to a diverse patient population, offering services over the phone and in various settings. The company is recognized by regional and national health plans, employers, and major corporations for its effectiveness in enhancing population health. Galileo's mission is to address complex healthcare challenges and foster closer connections between patients and providers.

SpecCheck

Seed Round in 2023
SpecCheck is an optical platform that offers comprehensive solutions for eye care specialists. It facilitates accurate prescription eyewear ordering and tracking, seamless billing, and improved communication among patients, eye doctors, and optical labs. By streamlining these processes, SpecCheck enables its users to enhance productivity and reduce costly errors, ultimately improving overall workflow in the eye care sector.

SoundMind

Seed Round in 2023
SoundMind is a mental health platform based in Los Angeles, California, that specializes in personalized music therapy to assist individuals in managing stress, anxiety, and trauma. Founded in 2020, the platform primarily targets students and marginalized communities, emphasizing the therapeutic benefits of music for mental wellness. SoundMind provides a data-driven solution that allows organizations to monitor the overall wellness of their members while offering users immediate access to music therapy for relaxation and mood improvement. By combining audio and visual elements, SoundMind aims to make music therapy accessible and effective for all, helping users to reset and refocus amidst life's challenges.

Previse

Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.

Wave Life

Seed Round in 2023
Wave Life is a new kind of mental health platform that makes emotional wellbeing an achievable part of everyday life. The app's mental health coach and toolkit empower users to live each day with intention. Mental health coaching helps to build self-awareness, discover values, and cope with stress.

Healium

Seed Round in 2023
Healium is a mental fitness tool that offers a drugless approach to managing anxiety, sleep, addiction, and burnout. The company utilizes patented technology that connects to biometric data from consumer wearables, such as smartwatches and EEG headbands, allowing users to monitor their brainwaves and heart rate. This information is used to create a reactive, immersive media experience that adapts to the user's bio-data. Healium's unique platform has been validated by eight peer-reviewed studies, demonstrating its effectiveness in reducing anxiety and improving mood within minutes. By leveraging existing sensors and devices, Healium provides a controlled virtual and augmented reality environment for users seeking to enhance their mental well-being.

Journey Clinical

Series A in 2023
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.

Juno Medical

Series A in 2022
Juno Care is a whole-family healthcare platform that provides modern open-access care for the entire family’s day-to-day needs, including pediatrics, women’s health, adult primary care, and same-day services. The company was founded in 2020 and is based in New York, New York, United States.

Disclo

Venture Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

Carbon Reform

Seed Round in 2022
Carbon Reform is a climate-tech startup that specializes in modular carbon capture and pollution-control devices aimed at reducing atmospheric CO2 levels. The company's technology is designed to retrofit commercial HVAC systems, enabling the capture and storage of carbon emissions while simultaneously eliminating volatile organic compounds, particulates, viruses, and bacteria from the air. This innovative approach not only enhances indoor air quality but also decreases overall building emissions and energy costs for operators. By employing a multi-phase methodology, Carbon Reform assesses air quality and collaborates with existing infrastructure to optimize performance, ultimately providing permanent carbon capture solutions and healthier indoor environments for occupants.

Yes Hearing

Series A in 2022
Yes Hearing is a company that specializes in providing hearing aid accessories and devices, primarily aimed at improving access for seniors with hearing impairments. Established in 2020 by Sam Shear and Oliver Philips in New York, the company facilitates healthcare access through innovative solutions, including home visit therapy and remote care. Its platform offers a diverse range of hearing aid products, ensuring that users can effectively address their hearing challenges with ease and convenience.

Gabbi

Seed Round in 2022
Gabbi is a healthcare software company focused on empowering women to better understand their health and take proactive steps in managing it. The platform utilizes artificial intelligence and clinical research to create a proprietary risk model that assesses a woman's lifetime risk of various diseases. Gabbi provides personalized and interactive action plans, along with tools for community engagement and support. Key features include a risk calculator specifically designed for breast cancer, virtual chat options, community support, and video appointments. By fostering a supportive environment and offering tailored health insights, Gabbi aims to reduce the incidence of preventable diseases and improve early diagnosis for women.

Shimmer

Seed Round in 2022
Shimmer provides a platform for 1:1 remote ADHD coaching. Our platform matches users to an ADHD coach who helps guide them towards identifying and meeting goals, maintaining a positive approach to change, and improving productivity while providing a source of accountability.

Qnovia

Series A in 2022
Qnovia is a biotechnology company that specializes in developing innovative drug delivery systems, focusing particularly on inhalation-based technologies. The company aims to enhance the delivery of a wide range of pharmaceuticals, including nicotine, by creating advanced aerosol devices and formulations that address the limitations of traditional drug delivery methods. Qnovia's platform not only seeks to improve patient outcomes through more effective inhaled therapies but also emphasizes responsible sourcing and transparency in product information. By prioritizing innovation and patient-centric solutions, Qnovia strives to contribute positively to public health and the overall experience of medication delivery.

Gameto

Venture Round in 2022
Gameto is a biotechnology company focused on improving female reproductive health through innovative therapies. Recognizing that women's health is an underserved area with limited treatment options, Gameto aims to develop advanced solutions that enhance patient outcomes. The company utilizes cellular engineering to create female reproductive cell lines, employing proprietary combinations of transcription factors to reprogram human induced pluripotent stem cells (hiPSCs) into engineered ovarian and endometrial cell lines that function similarly to natural cells. This platform supports a portfolio of cellular therapeutics targeting various female reproductive diseases. Gameto's flagship program, Fertilo, is designed to enhance the processes of in vitro fertilization (IVF) and egg freezing, making them shorter, safer, and more effective. Additional applications of Gameto's technology include Deovo, an organoid of the female reproductive system, and Ameno, a cell-based therapeutic aimed at alleviating the health issues associated with primary ovarian insufficiency and menopause.

Uplift Labs

Seed Round in 2022
Uplift Labs is a company founded in 2017 and headquartered in Palo Alto, California, that focuses on enhancing human movement through advanced technology. It offers an AI-powered motion analysis platform that provides detailed kinematic analysis to improve athletic performance and reduce the risk of injuries. By utilizing proprietary deep learning models and algorithms, Uplift Labs enables sports clubs and organizations to assess and refine movement patterns, thereby optimizing performance in sports, fitness, and daily activities.

Disclo

Pre Seed Round in 2022
Disclo is a HIPAA compliant platform enabling employers to collect, verify, and manage employee health disclosures and accommodation requests. Disclo helps employees secure the enhancements and protections they need to succeed in their careers without having to disclose their underlying medical condition to their employer.

BigHat Biosciences

Series B in 2022
BigHat Biosciences, Inc. is a biotechnology company based in San Carlos, California, founded in 2019. The company specializes in developing an automated platform that combines a wet laboratory with artificial intelligence and machine learning techniques for the production and characterization of antibodies. This innovative platform empowers drug developers to engineer antibodies and other therapeutic proteins with improved biophysical properties and complex functions. By leveraging AI-guided design capabilities, BigHat aims to create safer and more effective treatments for patients facing challenging diseases, thereby advancing the field of biotherapeutics.

Cartography Biosciences

Series A in 2022
Cartography Biosciences is a biotechnology company focused on developing cancer therapies through precision medicine. The company has created a platform-based cell therapy that utilizes single-cell analysis to identify innovative CAR-T targets. This approach allows for the design of cancer immunotherapies tailored to the safest and most effective targets. By combining molecular biology and computational methods, Cartography enables clients to advance their studies in the development of these targeted treatments, aiming to improve outcomes for cancer patients.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform focused on sexual care and performance health, offering comprehensive solutions for various reproductive health concerns. The company addresses issues such as sperm health and sexual performance in men, as well as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, including semen analysis and PCOS assessments, alongside telehealth consultations and nutraceutical supplements. Additionally, the platform employs artificial intelligence and computer vision technology to assist in selecting optimal embryos, thereby improving the success rates of assisted reproductive procedures. Overall, Kindly Health aims to make fertility treatments and sexual health care more affordable and accessible for patients.

Choiz

Seed Round in 2022
Choiz operates a healthcare platform designed to provide personalized medical treatments directly to patients in their homes. The service encompasses a comprehensive, end-to-end healthcare experience, which includes diagnosis, medication delivery, and ongoing care. By connecting patients with health professionals and facilitating the timely delivery of necessary medications, Choiz aims to make specialized care and treatment more accessible to everyone. The platform is built with a patient-centric approach, ensuring that individual needs are met throughout the healthcare journey.

STRIVE

Series A in 2022
STRIVE operates a fitness platform designed to enhance muscle performance for athletes, military personnel, and industrial workers. The company employs advanced sensors integrated into compression clothing to collect detailed muscle and movement data through methods such as surface electromyography and accelerometers. This information enables users to monitor muscle activity, track fatigue, and prevent injuries, ultimately promoting improved performance. STRIVE's technology is utilized by elite athletes across various sports, including NCAA, NFL, and MLS, providing them with actionable insights to maintain peak performance.

Swing Therapeutics

Series A in 2022
Swing Therapeutics focuses on developing innovative digital therapeutics aimed at helping individuals with chronic conditions. The company collaborates with leading researchers to create evidence-based treatments that enhance patient empowerment and control over their health. By offering novel prescription digital therapeutics, Swing supports patients in managing their illnesses more effectively, ultimately fostering improved health outcomes and promoting a more vibrant quality of life.

Circle

Convertible Note in 2022
Circle is a developer of insurance sales and member retention products tailored for health insurance carriers and their sales channels. The company's platform enables brokers to efficiently quote and enroll clients in various Medicare Advantage, supplemental, and prescription drug plans across the country. Utilizing advanced customer relationship management features, Circle's tools include commission tracking, contracting, licensing, lead generation, and digital Statements of Understanding, all designed to streamline the insurance sales process. By enhancing benefit management capabilities, Circle aims to reduce the financial burden of out-of-pocket medical costs for beneficiaries and improve overall sales efficiency for insurance companies. In addition, the company is working on a platform to facilitate telemedicine access for older adults during the COVID-19 pandemic, further supporting healthcare needs in the community.

MindRight Health

Seed Round in 2022
MindRight Health, Inc., founded in 2019 and based in Newark, New Jersey, offers mental health coaching through text messaging to support communities in overcoming trauma. The company aims to enhance health equity by providing accessible and inclusive mental health care, particularly for communities of color and low-income families. MindRight partners with healthcare payers and providers to deliver culturally-responsive coaching, ensuring that members receive support seven days a week throughout the year. By matching users with specific coaches based on their profiles, MindRight creates a continuum of nonclinical support tailored to youth who may avoid traditional clinical services due to stigma and accessibility issues. Additionally, the company supplies partners with real-time data on mental health needs within the community, helping to anticipate and prevent potential mental health crises.

Torigen Pharmaceuticals

Venture Round in 2022
Torigen Pharmaceuticals is dedicated to advancing cancer care for companion animals through innovative treatment options. Founded in 2013 and based in Farmington, Connecticut, the company focuses on developing immunotherapy solutions, particularly an experimental autologous cancer vaccine. This vaccine aims to activate the immune system to target specific tumor-associated antigens present on cancer cells, allowing for more effective detection and treatment of tumors. By providing alternatives to traditional, invasive methods such as surgeries and chemotherapy, Torigen seeks to improve the quality of life for pets facing cancer. The company builds on years of scientific research and is committed to pushing the boundaries of veterinary oncology.

OYE

Pre Seed Round in 2022
OYE is a wellness app focused on enhancing emotional well-being through mind-body practices and community engagement. The platform offers daily emotional check-ins, personalized goal setting, and mindful notifications to help users transform their emotions into creative actions. Available in both Spanish and English, OYE provides guided reflections and expressive movement practices aimed at shifting moods and improving interpersonal relationships. By fostering a supportive environment, OYE enables members of the Latino community to enhance their mental health, experience personal growth, and build connections regardless of their location.

Adni

Seed Round in 2022
Adni is transforming the career management of healthcare workers through an AI-powered super app that consolidates essential services into a single platform. The application facilitates connections between healthcare professionals and high-paying job opportunities while also offering resources for purchasing gear, updating credentials, and networking with peers. In addition, it provides daily educational content to enhance professional development. For healthcare employers, Adni serves as a comprehensive solution for both recruiting and retaining talent. Unlike conventional job boards and recruiting software, Adni focuses on fostering engagement and satisfaction among current staff through its unique platform, which includes features such as a white-labeled gamified intranet. This dual approach benefits both healthcare workers and employers by streamlining processes and enhancing overall engagement within the industry.

Curebase

Series B in 2022
Curebase is a company that develops software aimed at transforming the management of clinical trials. Founded in 2017 and based in San Francisco, California, its platform facilitates faster and more cost-effective trial execution by streamlining participant eligibility, enrollment, education, and consent processes. The software automates many manual steps and allows drug companies to efficiently distribute their trials to clinics. Additionally, it provides sponsors with access to real-time data, enabling them to monitor trial progress and manage information effectively. Curebase's services cater to various sectors, including medical devices, biotechnology, and digital health startups, enhancing the overall efficiency of clinical research.

Nelly

Seed Round in 2022
Nelly is a company that provides a digital tool aimed at streamlining patient onboarding and payment processes for medical practices. By significantly reducing administrative burdens, Nelly addresses a primary concern for healthcare professionals, who often cite bureaucracy as a major workplace challenge. The platform allows patients to complete admission forms and sign documents securely using their mobile devices, while also offering flexible payment options. This digitization of processes not only enhances the efficiency of medical practices but also aims to create a more patient-friendly experience during visits. Nelly's mission is to simplify the documentation and payment landscape in healthcare, ultimately benefiting both practitioners and patients.

Diligent Robotics

Series B in 2022
Diligent Robotics Inc. is a company based in Austin, Texas, that develops and manufactures hospital service robots, specifically designed to assist clinical and nursing staff with logistical tasks. Its flagship product, Moxi, is a robotic assistant equipped with advanced mobile manipulation, social intelligence, and human-guided learning capabilities. Moxi works collaboratively with healthcare teams, allowing clinical staff to focus more on direct patient care, thereby enhancing patient satisfaction and improving the overall quality and safety of service. Founded in 2017, Diligent Robotics aims to integrate artificial intelligence technologies into everyday environments, supporting healthcare providers in dynamic and semi-structured settings.

Rejuveron Life Sciences

Angel Round in 2022
Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.

Starling Medical

Seed Round in 2022
Starling Medical focuses on creating a remote patient monitoring platform that facilitates at-home urine diagnostics, integrating seamlessly into everyday bathroom routines. The company is developing a healthcare device that employs mass spectroscopy-based sensors to continuously monitor changes in urine composition. This technology aims to enable early detection of chronic health issues, allowing both patients and healthcare providers to intervene promptly and potentially prevent serious complications or hospitalizations. By offering predictive insights, Starling Medical aspires to enhance health outcomes through proactive monitoring.

One Body

Pre Seed Round in 2022
One Body is a developer of software solutions aimed at enhancing operational efficiency for physical therapy clinics and healthcare providers. The company's automation and machine learning technology facilitate insurance eligibility checks, streamlining the benefit verification process. By automating these tasks, One Body helps medical providers save time and reduce costs while improving claim approval rates. The platform also integrates seamlessly with Electronic Medical Records (EMR), providing clinics and digital health startups with better access to data, thereby supporting their financial performance and overall productivity.

SoundMind

Pre Seed Round in 2022
SoundMind is a mental health platform based in Los Angeles, California, that specializes in personalized music therapy to assist individuals in managing stress, anxiety, and trauma. Founded in 2020, the platform primarily targets students and marginalized communities, emphasizing the therapeutic benefits of music for mental wellness. SoundMind provides a data-driven solution that allows organizations to monitor the overall wellness of their members while offering users immediate access to music therapy for relaxation and mood improvement. By combining audio and visual elements, SoundMind aims to make music therapy accessible and effective for all, helping users to reset and refocus amidst life's challenges.

Minded

Seed Round in 2022
Minded is an online psychiatry practice focused on women, offering a telehealth platform designed to streamline the management of mental health prescriptions. The platform enables users to easily renew and refill prescriptions for anxiety and depression, delivering medications directly to their homes. This service aims to alleviate the challenges associated with traditional pharmacy visits, such as scheduling difficulties and the risk of running out of medication, ultimately providing a convenient solution for patients seeking mental health support.

Raydiant

Series B in 2022
Raydiant Inc., established in 2017 and headquartered in San Francisco, specializes in designing, developing, and providing an experience platform that connects employees and customers with brands across various industries such as banking, retail, hospitality, and healthcare. The company's solution comprises kiosks, virtual agents, and multimedia devices for screen management, enabling businesses to create engaging in-store experiences through digital signage. Raydiant works with over 5,000 brands worldwide, including notable clients like Johnson & Johnson and Chick-Fil-A, helping them streamline operations, enhance customer experiences, and drive sales growth.

Wavely Diagnostics

Seed Round in 2022
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Uplift Labs

Seed Round in 2022
Uplift Labs is a company founded in 2017 and headquartered in Palo Alto, California, that focuses on enhancing human movement through advanced technology. It offers an AI-powered motion analysis platform that provides detailed kinematic analysis to improve athletic performance and reduce the risk of injuries. By utilizing proprietary deep learning models and algorithms, Uplift Labs enables sports clubs and organizations to assess and refine movement patterns, thereby optimizing performance in sports, fitness, and daily activities.

Skippet

Seed Round in 2022
Skippet is a software developer that offers an AI-powered platform enabling users to create custom digital solutions without the need for coding. By simply describing their problems in plain English, users can leverage Skippet's advanced language models and system integration knowledge to generate or modify applications and workflows. This innovative approach allows individuals and organizations to effectively organize their work and adapt software to meet evolving needs. Additionally, Skippet's capabilities extend to health screening solutions that facilitate quick self-reporting for employees, helping organizations manage COVID-19 protocols and make informed decisions regarding workplace safety. Overall, Skippet empowers users to address their unique challenges through personalized technology solutions.

AmorSui

Seed Round in 2022
AmorSui is a modern protective apparel company that specializes in the design and innovation of medical gowns and lab jackets for healthcare professionals. Founded in 2020 by Beau Wangtrakuldee, PhD, the company emerged from a personal experience that highlighted the need for better protective gear. AmorSui's products are characterized by their antimicrobial and static-resistant properties, offering protection against bodily fluids while being reusable and recyclable. The company focuses on delivering high-quality, comfortable, and eco-friendly personal protective equipment that is entirely made and sourced in the USA. Additionally, AmorSui provides a platform for managing and procuring reusable kits, utilizing data analytics to monitor product life cycles, thereby helping hospitals and companies reduce costs and minimize waste while ensuring employee safety.

Suki

Series C in 2021
Suki is a technology company focused on enhancing healthcare documentation through AI-driven voice solutions. Its flagship product, Suki Assistant, allows physicians to complete administrative tasks more efficiently, significantly reducing the time spent on documentation. The company also offers a proprietary voice platform that leverages advanced natural language processing and machine learning technologies, ensuring high accuracy and a seamless user experience. By providing these innovative voice tools, Suki aims to alleviate the administrative burden on clinicians, ultimately transforming the healthcare technology landscape into a more assistive and integrated system.

Sonic Incytes Medical

Series A in 2021
Sonic Incytes Medical Corp is a medical device company based in Vancouver, Canada, focused on developing handheld ultrasound solutions for the assessment and monitoring of chronic liver diseases. Incorporated in 2012, the company aims to enhance routine liver health evaluation through non-invasive methods that provide reliable diagnostic accuracy. Its portable ultrasound devices are designed for point-of-care diagnostics and procedure guidance, enabling healthcare practitioners to improve the standard of care in quantifying conditions such as fatty liver disease. Through its innovative technology, Sonic Incytes seeks to facilitate better management of liver health for patients.

Limbix

Series A in 2021
Limbix is a prescription digital therapeutic company focused on developing mental health treatments specifically for adolescents. The company combines clinical expertise with technological innovation, leveraging a diverse team of clinicians, product designers, researchers, and engineers to create effective therapeutic solutions. Limbix's flagship product, SparkRx, is a digital therapeutic designed to assist licensed healthcare professionals in treating young patients dealing with depression, anxiety, and other mental health issues. By offering evidence-based interventions, Limbix aims to enhance the lives of teenagers facing mental health challenges.

CareAlign

Seed Round in 2021
CareAlign offers a patient-centric task management tool that assists clinicians in tracking, managing, and coordinating clinical care. The platform provides an intuitive interface for assigning tasks with specific dates and times, categorizing them by urgency, and reviewing completed tasks. Additionally, CareAlign has developed a real-time data system that consolidates information from various sources into a cohesive and easily navigable display. This system enhances clinicians' understanding of patients' clinical statuses, ultimately improving care coordination.

OxiWear

Pre Seed Round in 2021
OxiWear develops innovative ear-wearable devices that provide continuous oxygen monitoring and emergency alerts to help detect and prevent silent hypoxia, particularly in individuals with pulmonary hypertension, those at high altitudes, or engaged in high-intensity activities, including during COVID-19. The company's patented pulse oximeter is designed for both clinical and consumer use, allowing patients to monitor their oxygen levels effectively. By offering real-time monitoring and alerts, OxiWear enhances patient safety and peace of mind, ensuring that individuals can obtain timely medical assistance when necessary.

Valera Health

Venture Round in 2021
Valera Health, established in 2015, operates a behavioral healthcare platform focused on delivering personalized mental health services to individuals with a range of conditions from mild to severe, including depression and schizophrenia. The company integrates digital technology and data science with traditional clinical services to enhance patient outcomes and address the needs of hard-to-reach populations. By providing a comprehensive approach that combines therapy, medication, and continuous connectivity with care teams, Valera Health aims to offer efficient mental healthcare solutions, particularly for employers seeking to improve access to mental health support for their employees.

Ruth Health

Seed Round in 2021
Ruth Health is a telehealth facility focused on women's and prenatal care, aiming to empower parents throughout their pregnancy journey and beyond. By utilizing evidence-based expertise, the company enhances access to childbirth services, making them more affordable and enjoyable. Ruth Health's platform offers medical consultations and information on postpartum care, addressing common women's health issues such as painful sex and unwanted urination. It also provides at-home ultrasound services and online consultations with healthcare professionals, enabling women to take control of their health and confidently navigate family planning and parenthood.

Aether Bio

Seed Round in 2021
Aether Bio is a technology company that focuses on re-purposing enzymes to create new compounds using machine learning. By integrating machine learning with high-throughput robotic laboratories, Aether Bio engineers enzymes rapidly and enables massively parallelized experimentation. This innovative approach generates significantly larger datasets compared to competitors, allowing researchers to manufacture complex and novel products more efficiently and at a lower cost. The company's technology aims to provide healthcare institutions with sustainable and affordable chemicals and materials essential for their operations.

Zeit Medical

Seed Round in 2021
Zeit Medical specializes in the development of innovative technology for diagnosing and treating neurological injuries. Founded in 2019 by Urs Naber and Orestis Vardoulis, the company has created a headband that continuously monitors the electrical activity of the brain. This device integrates seamlessly with existing electroencephalogram (EEG) systems and facilitates automated pre-screening and annotation of extensive datasets. By identifying specific patterns in EEG readings, Zeit Medical enables physicians to detect the onset of strokes and provide precise treatment, significantly improving patient outcomes in neurological care.

BIOMILQ

Series A in 2021
BIOMILQ is a Durham, North Carolina-based startup founded in 2020 that specializes in producing nutritionally equivalent human breast milk using cultured human mammary cells. The company has developed a mammary biomanufacturing platform aimed at creating bioauthentic human milk ingredients that support better health outcomes for infants. By leveraging advanced technology, BIOMILQ provides an alternative for mothers and caregivers seeking a nutritious and sustainable feeding option, promoting essential aspects of infant development, including immune, gut, and neurological health. The company's innovative approach empowers families with a comprehensive solution for early-life nutrition.

Options MD

Pre Seed Round in 2021
Options MD is a telemedicine platform focused on delivering personalized care for individuals experiencing severe and treatment-resistant mental illnesses. The platform utilizes artificial intelligence to match patients with innovative depression care options provided by psychiatric experts. By streamlining the referral process to in-house specialists, Options MD enables patients to access appropriate medical care more efficiently, aiming to improve their treatment outcomes.

Sonavi Labs

Seed Round in 2021
Sonavi Labs, Inc. is a Baltimore-based company that specializes in the development of medical devices and artificial intelligence-based software aimed at respiratory monitoring and diagnostic support. Founded in 2017, the company focuses on creating innovative products that analyze body sounds to assist in the diagnosis of respiratory diseases. By leveraging advanced technology, Sonavi Labs enables healthcare providers to detect, monitor, and potentially predict respiratory conditions by identifying abnormalities in the sounds produced by the body. This approach enhances the capabilities of medical professionals and aims to improve the patient experience in managing respiratory health.

Eleos Health

Seed Round in 2021
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Kenshō Health

Seed Round in 2021
Kenshō is a health company based in Los Angeles that operates an online platform designed to connect users with verified wellness providers. Founded by entrepreneurs Krista Berlincourt and Danny Steiner, the company emphasizes a holistic approach to health, integrating mind, body, and spirit. Kenshō's platform allows users to easily find and book a variety of wellness services, including acupuncture, massage, yoga, naturopathy, and meditation, facilitating access to curated professionals without the need for in-person visits. By combining scientific research with personalization technology, Kenshō aims to simplify the journey toward holistic health, providing users with trustworthy answers and resources for maintaining a balanced and healthy lifestyle.

Circle

Seed Round in 2021
Circle is a developer of insurance sales and member retention products tailored for health insurance carriers and their sales channels. The company's platform enables brokers to efficiently quote and enroll clients in various Medicare Advantage, supplemental, and prescription drug plans across the country. Utilizing advanced customer relationship management features, Circle's tools include commission tracking, contracting, licensing, lead generation, and digital Statements of Understanding, all designed to streamline the insurance sales process. By enhancing benefit management capabilities, Circle aims to reduce the financial burden of out-of-pocket medical costs for beneficiaries and improve overall sales efficiency for insurance companies. In addition, the company is working on a platform to facilitate telemedicine access for older adults during the COVID-19 pandemic, further supporting healthcare needs in the community.

Woebot Health

Series B in 2021
Woebot Health is a digital mental healthcare provider that focuses on delivering personalized support through an innovative platform. This platform integrates advanced artificial intelligence and natural language processing with established therapeutic techniques to create engaging mental health tools. At the core of its offering is Woebot, a relational agent designed to provide continuous, empathic, and personalized care. By leveraging these technologies, Woebot Health enables individuals and businesses to access effective mental health support conveniently and seamlessly, fitting into everyday life and promoting overall well-being.

Crescent Health

Pre Seed Round in 2021
Crescent Health is working to make sleep health accessible to all. It hastens the development of individual health, beginning with sleep. They are employed by meet sleep coach. Connecting a sleep monitor to an app get monthly customized sleep plans, track sleep health, and find the ideal schedule.

Ruth Health

Pre Seed Round in 2021
Ruth Health is a telehealth facility focused on women's and prenatal care, aiming to empower parents throughout their pregnancy journey and beyond. By utilizing evidence-based expertise, the company enhances access to childbirth services, making them more affordable and enjoyable. Ruth Health's platform offers medical consultations and information on postpartum care, addressing common women's health issues such as painful sex and unwanted urination. It also provides at-home ultrasound services and online consultations with healthcare professionals, enabling women to take control of their health and confidently navigate family planning and parenthood.

Brightline

Series B in 2021
Brightline, Inc. is a provider of pediatric behavioral health care services, established in 2019 and headquartered in Palo Alto, California. The company offers a range of services including behavior therapy, psychiatry and medication support, speech-language therapy, and occupational therapy. Brightline operates as a technology-enabled behavioral health home, utilizing innovative technology and virtual services to deliver integrated care. Its collaborative care team focuses on supporting children throughout their developmental stages and addressing the needs of their families. Brightline was previously known as Emilio Health, Inc. and rebranded in May 2020.

Protenus

Series D in 2021
Protenus, Inc. is a company based in Baltimore, Maryland, that specializes in developing a compliance analytics platform for healthcare organizations in the United States. Founded in 2014, Protenus utilizes artificial intelligence to audit access to patient records, helping to identify risks such as inappropriate access and the misuse of controlled substances by hospital staff. The platform enables healthcare providers to proactively detect policy violations and anomalous behaviors, ultimately supporting safer patient outcomes while safeguarding the integrity of health data. Through its innovative solutions, Protenus aims to reduce risk and protect the reputation of healthcare organizations, affirming its commitment to both patient safety and organizational accountability.

Ever/Body

Series B in 2021
Ever/Body is a New York-based provider of dermatology and cosmetic treatments, focusing on demystifying the field of cosmetic dermatology. The company offers a range of services, including injectable treatments, high-tech facials, and non-surgical body treatments. These medically-tested procedures are designed to deliver optimal results, such as reducing wrinkles and enhancing overall appearance, allowing clients to achieve a more youthful and rejuvenated look. By prioritizing client preferences, Ever/Body aims to make beauty and cosmetic care accessible and effective.

Gilgamesh Pharmaceuticals

Series A in 2021
Gilgamesh Pharmaceuticals, Inc. is a preclinical biotechnology company based in New York that specializes in developing novel psychotropic drugs aimed at treating mental illnesses. Established in 2019, the company focuses on creating innovative compounds that enhance the therapeutic benefits of classic psychedelics while improving safety, tolerability, duration, and efficacy. Gilgamesh addresses the growing global mental health crisis by providing treatments for various neuropsychiatric conditions, including depression, anxiety, substance use disorders, and stress-related issues. Through a combination of medicinal chemistry and drug development expertise, the company aims to accelerate the availability of effective therapies, ultimately improving the quality of life for individuals suffering from central nervous system disorders.

CareRev

Series A in 2021
CareRev is a healthcare staffing marketplace that connects medical facilities directly with per diem healthcare professionals, eliminating the need for vendors or agencies. Its online platform allows hospitals and outpatient facilities to efficiently fill shifts by accessing a pool of flexible clinical talent. This model not only expedites the staffing process but also helps facilities reduce costs and maintain appropriate nurse-to-patient ratios, ultimately enhancing the quality of patient care. By facilitating direct communication between healthcare providers and staff, CareRev empowers professionals to choose their work schedules and locations, promoting greater flexibility in the healthcare workforce. The company has received funding from notable investors, including Y Combinator and several prominent business angels.

Willow

Series C in 2021
Willow Inc., established in 2014 and headquartered in Mountain View, California, specializes in the manufacture of wearable breast pumps for women. The company offers a range of products including milk bags, accessories such as flanges and tubes, and replacement parts. Willow's flagship product is an in-bra wearable breast pump designed to provide mothers with mobility and hands-free convenience during breastfeeding. The company also provides pumping bras, cases, and other breastfeeding essentials.

Territory Foods

Series B in 2021
Territory Foods is a meal delivery service that focuses on providing chef-prepared, nutritionist-approved meals tailored to various dietary preferences. Established in 2011 and headquartered in Arlington, VA, the company offers a diverse range of freshly-made meals designed by culinary professionals and nutrition experts. Its menus feature artisan dishes that are responsibly sourced and free of refined sugars, gluten, and dairy, catering to health-conscious consumers. Meals can be customized to fit dietary needs such as Vegan, Vegetarian, Whole30, and Keto, making it easier for customers to maintain healthy eating habits. Territory Foods employs a proprietary algorithm to ensure a rotating menu that keeps meal options varied and engaging.

Alloy Therapeutics

Series C in 2021
Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.

BrightInsight

Series C in 2021
BrightInsight operates a digital health platform tailored for biopharma and medtech companies, focusing on the development and optimization of regulated drugs, devices, and software. Founded in 2017 and headquartered in San Jose, California, the company offers a global regulated platform that utilizes Internet of Things (IoT) technology. This platform facilitates the capture, transmission, and analysis of data from connected medical devices, combination products, and digital therapeutics. By adhering to rigorous security, privacy, and regulatory standards, BrightInsight enables its clients to enhance patient adherence and engagement, streamline their processes, and accelerate time to market while reducing implementation costs. With an additional office in Hägglingen, Switzerland, BrightInsight is positioned to support customers in navigating the complexities of the digital health landscape.

Cleo

Series C in 2021
Cleo is a family support system that employers offer working parents, by helping families navigate their journey from fertility, to pregnancy, to parenting of newborns, infants, toddlers, and children to age 5. Employers choose Cleo as a strategic partner to power their culture transformation and see increased employee retention, more diverse and inclusive workplaces, and reduced health claims. Cleo supports parents globally in 50+ countries and works with forward-thinking companies like eBay, LinkedIn, Uber, and Straus Family Creamery and many others. Cleo is headquartered in San Francisco and is backed by Felicis Ventures, Forerunner Ventures, Greylock Partners, and NEA. Learn more at hicleo.com.

Breathwrk

Seed Round in 2021
Breathwrk, Inc. is a company that develops a mobile application focused on guided breathing exercises aimed at enhancing mental and physical wellness. Founded in 2019 and based in Venice, California, the Breathwrk app provides users with science-backed techniques designed to alleviate anxiety, improve sleep quality, increase energy levels, and enhance athletic performance. The application offers easy-to-follow breathing exercises that help manage stress, reduce blood pressure, and improve overall mood and focus. By promoting breath work, Breathwrk seeks to address a variety of issues, including sleep disorders, low energy, and racing thoughts, making it a valuable resource for users looking to improve their well-being.

ELANZA Wellness

Pre Seed Round in 2021
ELANZA Wellness is a virtual chronic care platform designed specifically for individuals with endometriosis and other chronic reproductive health conditions. The platform aims to provide comprehensive support by offering access to medical specialists, evidence-based therapies, and personalized treatment plans that promote symptom relief. ELANZA Wellness focuses on a whole-person care approach, developed by multidisciplinary teams, to ensure that patients feel heard and understood throughout their healthcare journey. By enabling users to access therapeutic programs and make informed lifestyle changes, the platform empowers individuals to take control of their health and well-being, ultimately fostering a better quality of life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.